Advertisement

Business

Updated on: Monday, January 10, 2022, 02:25 PM IST

Arch Pharmalabs partners with Orochem Technologies for pharmaceutical, other applications

The Agreement allows Arch to collaborate with Orochem for using Orochem’s proprietary Simulated Moving Bed (SMB) platform for Pharmaceutical and other applications./ Representative image |

The Agreement allows Arch to collaborate with Orochem for using Orochem’s proprietary Simulated Moving Bed (SMB) platform for Pharmaceutical and other applications./ Representative image |

Advertisement

Arch Pharmalabs Ltd., India, announced the signing of a Technology Access & Services Agreement with Orochem Technologies Inc., USA, on an exclusive basis.

The Agreement allows Arch to collaborate with Orochem for using Orochem’s proprietary Simulated Moving Bed (SMB) platform for Pharmaceutical and other applications. Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation.

It is used to separate one chemical compound or one class of chemical compounds from one or more other chemical compounds to provide significant quantities of the purified or enriched material, more cost effectively than obtained using simple (batch) chromatography.

SMB Technology provides for the “highest purities” of industrial or “metric ton” scale purification for API’s, nutritional supplements, fatty acids, and specialty sugars.

Ajit Kamath, Chairman & Managing Director, Arch Pharmalabs Ltd. commented, “We are extremely excited with the technology collaboration we have signed with Orochem Technologies Inc. for use of their proprietary SMB process, under license to us for various applications. Orochem Technologies Inc. is based in Naperville, Illinois, USA, and has been a pioneer in large scale chromatographic purification of small and large molecules for the pharma and nutraceutical industry."

"The partnership with Orochem provides Arch Pharmalabs vast opportunities for separation and purification of various small molecule Active Pharmaceutical Ingredients from its three USFDA approved facilities in India. It also allows Arch Pharmalabs to collaborate with other pharmaceutical companies to conduct contract manufacturing of APIs at its Vitalife facility in Gurgaon."

"We look forward to this association with Orochem and expand the applications of their proprietary platform and offer unique solutions to the pharma industry worldwide.”

Dr. Asha Oroskar, CEO of Orochem Technologies Inc. commented, “We are very pleased with this new partnership with Arch Pharmalabs. Over the past 25 years Orochem Technologies Inc. has been successful in commercializing the SMB Chromatography Technology around the world. Applications include: Omega-3, Phospholipids, Sugars, Active Pharma Ingredients, Proteins etc. from Kilo to ton scale."

"The commercialization of the SMB Technology allows Worldwide Pharma and Nutraceutical Industry an avenue to shorten product development cycle time for new and generic active ingredients.”

(With inputs from PTI)

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Published on: Monday, January 10, 2022, 02:25 PM IST
Advertisement